×
About 60,990 results

ALLMedicine™ Multiple Sclerosis Center

Research & Reviews  20,231 results

Advances In Neurologic Care
https://www.mdedge.com/fedprac/article/253857/neurology/advances-neurologic-care

May 20th, 2022 - Read Now Pharmacist Impact on Access to Care in an Epilepsy Clinic MRI Protocols for Veterans With Multiple Sclerosis Neuroimaging in the Era of Artificial Intelligence Autonomic Dysfunction in CADASIL Syndrome.

Efficacy of different intensity of aquatic exercise in enhancing remyelination and neur...
https://doi.org/10.17219/acem/148112
Advances in Clinical and Experimental Medicine : Official... Begum Z, Subramanian V et. al.

May 20th, 2022 - Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). Most exercise studies concentrate on the impact of exercise on cardiovascular system; this study aims to present the effects of exercise of varying int...

COVID-19 Ozanimod Intervention Study
https://clinicaltrials.gov/ct2/show/NCT04405102

May 20th, 2022 - The virus SARS-CoV-2 causes severe pneumonia which, in a proportion of patients progresses towards an Acute Respiratory Distress Syndrome (ARDS) mainly related to the antiviral immune response. To date, there is no available treatment that signifi...

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
https://clinicaltrials.gov/ct2/show/NCT01730131

May 20th, 2022 - The objective of this study is to examine the risk factors and natural course of JCV infection and progressive multifocal leukoencephalopathy (PML). PML is a devastating, demyelinating neurological disease affecting the brain of patients with a co...

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
https://clinicaltrials.gov/ct2/show/NCT03109288

May 20th, 2022 - Objective Multiple inflammatory and neurodegenerative mechanisms drive progression of disability in fully established multiple sclerosis (MS); therefore, it is unlikely that a single therapeutic agent will be curative. Analogous to cardiovascular ...

see more →

Guidelines  15 results

Vision Problems in Multiple Sclerosis.
https://doi.org/10.1016/j.apmr.2020.08.003
Archives of Physical Medicine and Rehabilitation; Costa SL, Pandey K et. al.

Sep 29th, 2020 - Vision Problems in Multiple Sclerosis.|2020|Costa SL,Pandey K,Hrdina J,Rondon M,Devos H,|

Serum neurofilament light as a biomarker in progressive multiple sclerosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538221
Neurology Kapoor R, Smith KE et. al.

Jul 18th, 2020 - There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes...

Practical Sleep Information for People With Multiple Sclerosis.
https://doi.org/10.1016/j.apmr.2020.03.009
Archives of Physical Medicine and Rehabilitation; Siengsukon C, Karahan AY et. al.

May 14th, 2020 - Practical Sleep Information for People With Multiple Sclerosis.|2020|Siengsukon C,Karahan AY,Strober L,|

Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis...
https://doi.org/10.1016/j.msard.2019.04.004
Multiple Sclerosis and Related Disorders; Lebrun C, Vukusic S et. al.

Jun 5th, 2019 - To establish recommendations on immunization for patients with multiple sclerosis (MS) BACKGROUND: Vaccines have been suspected in the past to trigger MS and relapses. With the extension of the immunoactive treatment arsenal, other concerns have b...

ESPEN guideline clinical nutrition in neurology.
https://doi.org/10.1016/j.clnu.2017.09.003
Clinical Nutrition (Edinburgh, Scotland); Burgos R, Bretón I et. al.

Dec 25th, 2017 - Neurological diseases are frequently associated with swallowing disorders and malnutrition. Moreover, patients with neurological diseases are at increased risk of micronutrient deficiency and dehydration. On the other hand, nutritional factors may...

see more →

Drugs  381 results see all →

Clinicaltrials.gov  804 results

COVID-19 Ozanimod Intervention Study
https://clinicaltrials.gov/ct2/show/NCT04405102

May 20th, 2022 - The virus SARS-CoV-2 causes severe pneumonia which, in a proportion of patients progresses towards an Acute Respiratory Distress Syndrome (ARDS) mainly related to the antiviral immune response. To date, there is no available treatment that signifi...

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
https://clinicaltrials.gov/ct2/show/NCT01730131

May 20th, 2022 - The objective of this study is to examine the risk factors and natural course of JCV infection and progressive multifocal leukoencephalopathy (PML). PML is a devastating, demyelinating neurological disease affecting the brain of patients with a co...

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
https://clinicaltrials.gov/ct2/show/NCT03109288

May 20th, 2022 - Objective Multiple inflammatory and neurodegenerative mechanisms drive progression of disability in fully established multiple sclerosis (MS); therefore, it is unlikely that a single therapeutic agent will be curative. Analogous to cardiovascular ...

Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
https://clinicaltrials.gov/ct2/show/NCT04025554

May 20th, 2022 - Objective: The overall goal of this study is to determine the safety, tolerability, and radiological efficacy of up to 12 weeks of subcutaneous injection of anakinra in people with multiple sclerosis and evidence, by magnetic resonance imaging (MR...

Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis
https://clinicaltrials.gov/ct2/show/NCT04834401

May 19th, 2022 - COVID-19 is a potentially fatal respiratory illness, caused by the novel coronavirus, SARS-CoV-2, which developed into a pandemic claiming the lives of over 500,000 people in the United States and over 2.5 million worldwide. Antibodies against the...

see more →

News  2,912 results

Advances In Neurologic Care
https://www.mdedge.com/fedprac/article/253857/neurology/advances-neurologic-care

May 20th, 2022 - Read Now Pharmacist Impact on Access to Care in an Epilepsy Clinic MRI Protocols for Veterans With Multiple Sclerosis Neuroimaging in the Era of Artificial Intelligence Autonomic Dysfunction in CADASIL Syndrome.

Long-term treatment with siponimod is effective and safe in SPMS
https://www.mdedge.com/neurology/msresourcecenter/article/254733/multiple-sclerosis/long-term-treatment-siponimod-effective

May 18th, 2022 - Key clinical point : Continuous siponimod treatment for up to >5 years showed sustained efficacy and a consistent safety profile in patients with secondary progressive multiple sclerosis (SPMS). Major finding: The risk for 6-month confirmed disabi.

Teriflunomide effective and well-tolerated in patients with RRMS
https://www.mdedge.com/neurology/msresourcecenter/article/254732/multiple-sclerosis/teriflunomide-effective-and-well

May 18th, 2022 - Key clinical point: Teriflunomide is effective and well-tolerated in treatment-naive patients with relapsing-remitting multiple sclerosis (RRMS), with females with mild disease activity and lesser disability most likely to benefit. Major finding:.

Less Frequent Dosing With MS Drug Safe With No Loss of Efficacy
https://www.medscape.com/viewarticle/973503

May 5th, 2022 - Most patients with relapsing-remitting multiple sclerosis (RRMS) who are stable on natalizumab (Tysabri, Biogen) administered once every 4 weeks (Q4W) may be able to safely switch to a once every 6 weeks (Q6W) dosing interval with no clinically me...

Using MRI to Track Cerebral Damage in Multiple Sclerosis
https://www.medscape.com/viewarticle/973502

May 5th, 2022 - The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Among patients with relapsing-remitting multiple sclerosis (RRMS), those who had a better clinical course were found to ...

see more →

Patient Education  53 results see all →